Trademark: 90713374
Word
IFORMULATE
Status
Registered
Status Code
700
Status Date
Tuesday, May 31, 2022
Serial Number
90713374
Registration Number
6743350
Registration Date
Tuesday, May 31, 2022
Mark Type
4000
Filing Date
Saturday, May 15, 2021
Published for Opposition
Tuesday, March 15, 2022

Trademark Owner History
HTD Biosystems, Inc. - Original Registrant

Classifications
1 Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of liquid formulations of proteins, antibodies, peptides, and other small molecules, and for use in evaluating their respective solubility properties, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of nanoparticle formulations, including investigating parameters related to drug release, particle size, aggregations, and drug integrity, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of vaccine stability formulations, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of antibody conjugates and antibody drug conjugates (ADCs), all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of diagnostic reagents and for use in evaluating their stability and compatibility in various formulations with respect to the effect of pH, ionic strength, buffer and stability concentrations, all the foregoing using Design of Experiments Approach in a multivariate fashion
42 Scientific research services related to providing an optimum process for identifying stable formulations for biotech drugs such as protein, peptides, and small molecules, using advanced Design of Experiments strategy; Scientific laboratory services related to providing an optimum process for identifying stable formulations for biotech drugs such as protein, peptides, and small molecules, using advanced Design of Experiments strategy
I FORMULATE

Trademark Events
Apr 20, 2023
Teas Change Of Correspondence Received
Apr 20, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Apr 20, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 20, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 31, 2022
Notice Of Registration Confirmation Emailed
May 31, 2022
Registered-Principal Register
Mar 15, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 15, 2022
Published For Opposition
Feb 23, 2022
Notification Of Notice Of Publication E-Mailed
Feb 10, 2022
Law Office Publication Review Completed
Feb 8, 2022
Assigned To Lie
Feb 4, 2022
Approved For Pub - Principal Register
Jan 31, 2022
Examiner's Amendment Entered
Jan 31, 2022
Notification Of Examiners Amendment E-Mailed
Jan 31, 2022
Examiners Amendment E-Mailed
Jan 31, 2022
Examiners Amendment -Written
Jan 25, 2022
Assigned To Examiner
Aug 13, 2021
New Application Office Supplied Data Entered
May 19, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24